<DOC>
	<DOCNO>NCT02873013</DOCNO>
	<brief_summary>This study target patient receive histopathological diagnosis prostate cancer undergo treatment various form , include active PSA surveillance , surgical treatment , radiotherapy , endocrine therapy , chemotherapy . The study survey information patient time diagnosis , clinical staging , detail initial treatment , status disease progression , prognosis end point study . The purpose study clarify distribution staging , actual status treatment choice treatment outcome .</brief_summary>
	<brief_title>Asia Study Group Prostate Cancer ( A-CaP Study )</brief_title>
	<detailed_description>The A-CaP collect information linkable anonymized format medical institution Asian country participate study engage data analysis . J-CaP previous experience engage similar study 2010 wll sponsor A-CaP study , aggregate result report . The registration period study three year follow 7 year follow-up study , research implement across wider range Asian country , new institution participate purpose study . As study observational study acquisition data relatively simple , content study almost identical study conduct J-CaP 2010 , system research implementation already establish J-CaP .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patients receive histopathological diagnosis prostate cancer January 1,2016 , December 31,2018 . Patients , receive diagnosis within abovementioned period , begin initial treatment prostate cancer ( include active surveillance ) . Patients either hospitalized outpatient . â€¢ Patients information time diagnosis , include histopathological diagnosis , acquire .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>observational study</keyword>
</DOC>